Chiesi, Arbor Secure EU Orphan Status for ABO-101
PARMA, Italy & CAMBRIDGE, Mass., June 25, 2026 Chiesi Group and Arbor Biotechnologies have achieved a significant regulatory milestone...
amyloid beta
Advertisement
Ionis Partners with Recordati to Expand Zilganersen Globally
CARLSBAD, Calif., June 25, 2026 Ionis Pharmaceuticals has entered into a landmark global licensing agreement with Recordati to accelerate...
Anivive Wins FDA Approval for First Oral Canine Lymphoma Drug
LONG BEACH, Calif., June 26, 2026 Anivive Lifesciences has achieved a landmark milestone after the U.S. Food and Drug...
NeuroSense PrimeC Shows Positive Phase 2 Alzheimer’s Biomarker Data
CAMBRIDGE, Mass., June 25, 2026 NeuroSense Therapeutics Ltd. announced positive biomarker findings from its Phase 2 randomized, double-blind, placebo-controlled...
AlzeCure and Eli Lilly Partner on Alzheimer’s Drug ACD680
STOCKHOLM, Sweden, June 9, 2026 AlzeCure Pharma announced a global collaboration and out-licensing agreement with Eli Lilly and Company...
Advertisements
AC Immune Advances ACI-24 Alzheimer’s Trial Expansion
LAUSANNE, Switzerland, April 2026 AC Immune SA announced continued progress in its Phase 1b/2 ABATE clinical trial evaluating ACI-24,...
FDA Accepts LEQEMBI sBLA, Expanding At-Home Alzheimer’s Therapy
Tokyo & Cambridge, Massachusetts, January 25, 2026 — Eisai Co., Ltd. and Biogen Inc. announced that the U.S. Food...
Advertisement
